Search | GAKEPS

added blog Health

2025-04-17 10:50:20

Fabre-Kramer’s Exxua Receives FDA Approval: A New Hope for Major Depressive Disorder Patients

In a monumental achievement for Fabre-Kramer Pharmaceuticals, the company has received FDA approval for Exxua, offering a new treatment option for patients with Major Depressive Disorder (MDD). This approval is a significant step forward in the ongoing battle against depression, providing fresh hope for those who have struggled with other treatments. Exxua Clinical Trials: Proof of...

0 Comments 0 Shares 794 Views 0 Reviews